Advanced Oncotherapy

London, United Kingdom Founded: 1994 • Age: 32 yrs
Provider of proton beam therapy system for the treatment of cancer
Annual revenue - Latest available
Total funding - 9 rounds
Employees 157 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Advanced Oncotherapy

Advanced Oncotherapy is a company based in London (United Kingdom) founded in 1994. The company has 157 employees as of December 31, 2021. Advanced Oncotherapy operates in a competitive market with competitors including Terapet, B dot Medical, P-Cure, HIL Medical and Provision Healthcare, among others.

  • Headquarter London, United Kingdom
  • Employees 157 as on 31 Dec, 2021
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Advanced Oncotherapy Plc
  • Date of Incorporation 15 Sep, 2005
  • Jurisdiction LONDON, ENGLAND
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    -$32.47 M (USD)
    -22
    as on Dec 31, 2020
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    157

    as on Dec 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Advanced Oncotherapy

Headcount 50-200
Employee Profiles 20
Employee Profiles
People
Margaux Vallé
Project Manager
People
Paweł Ptasznik
Control System Engineer C++
People
Olivier Bietzer
System Validation & Clinical Trials Project Manager
People
Michael Bradfield
Director

Unlock access to complete

Funding Insights of Advanced Oncotherapy

Investors in Advanced Oncotherapy

Advanced Oncotherapy has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include DNCA Finance.

All
Institutional
Investor Description Founded Year Domain Location
DNCA Finance is engaged in asset management and investment services.
Locked Locked Locked
Premium access

Investor details for Advanced Oncotherapy

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Advanced Oncotherapy

Investments
Premium access

Investment portfolio details for Advanced Oncotherapy

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Advanced Oncotherapy

Premium access

Detailed financials for Advanced Oncotherapy

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Advanced Oncotherapy Comparisons

Advanced Oncotherapy Primary company
Description
Provider of proton beam therapy system for the treatment of ...
Location
London, United Kingdom
Founded Year
1994
Annual Revenue
Not available
Net Profit
-$32.47 M (USD)
EBITDA
Not available
Employees
157
As of 2021
Premium access

Peer comparison for Advanced Oncotherapy

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Advanced Oncotherapy

Advanced Oncotherapy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Terapet, B dot Medical, P-Cure, HIL Medical and Provision Healthcare, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Terapet is focused on developing imaging solutions for proton therapy.
Locked Locked Locked
Proton beam therapeutic devices for cancer treatment are developed.
Locked Locked Locked
Image-guided proton therapy for cancer treatment is provided.
Locked Locked Locked
Proton-beam radiotherapy devices are developed for solid tumor treatment.
Locked Locked Locked
Proton therapy system for cancer treatment is developed.
Premium access

Detailed competitors of Advanced Oncotherapy

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Advanced Oncotherapy

Premium access

Complete news archive for Advanced Oncotherapy

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Advanced Oncotherapy

Advanced Oncotherapy was founded in 1994 and raised its 1st funding round 24 years after it was founded.

Advanced Oncotherapy is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Nicolas Serandour is the current CEO of Advanced Oncotherapy.

As of Dec 31, 2021, the latest employee count at Advanced Oncotherapy is 157.

Advanced Oncotherapy was founded in 1994 in London, United Kingdom, and operates in the medical technology sector focused on oncology. Proton beam therapy systems, including the LIGHT product, are developed for cancer treatment. These systems incorporate a proton source, radio-frequency quadrupole, accelerators, nozzle for dose delivery, patient positioning, and imaging components to target tumors precisely. Operations emphasize integration of these elements for clinical applications.

Advanced Oncotherapy's top competitors include P-Cure, Terapet and HIL Medical.

Advanced Oncotherapy has 1 investor. Key investors include DNCA Finance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available